feed,title,long_url,short_url
BioRxiv,Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages,https://biorxiv.org/cgi/content/short/2024.08.12.607496v1?rss=1,https://da.gd/FaqkZf
